FDA Enforcement Class II Ongoing

Sensi Disc Amoxicillin with Clavulanic Acid 20/10 ¿g, Catalog No. 231628 and 231629.¿ These discs are used for semi-quantitative in vitro susceptibility testing

Recall: Z-1011-2024 · Reported February 14, 2024

Enforcement

Recall Number
Z-1011-2024
Event ID
93789
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Becton Dickinson & Co.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 14, 2024
Initiation Date
January 8, 2024
Classification Date
February 8, 2024
Address
7 Loveton Cir, Sparks, MD, 21152-9212, United States

Description

Sensi Disc Amoxicillin with Clavulanic Acid 20/10 ¿g, Catalog No. 231628 and 231629.¿ These discs are used for semi-quantitative in vitro susceptibility testing

Reason

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Code Info

Catalog No. 231628 UDI-DI 00382902316282 Lots 2090490 2146520 2210201 2276143 3062095; Catalog No. 231629¿¿ UDI-DI 30382902316290 Lots 3163306 3163307 3163310 3254307 3254309 3271840 3271853 2146520 2146526 2147225 2210201 2224295 2276143 2276144 3003894 3062095 3090649

Distribution

Domestic distribution nationwide. International distribution worldwide.

Quantity

2,363,168 total units